1. Home
  2. Stock quotes
  3. RedHill Biopharma Ltd.
  4. Financial Ratios
RedHill Biopharma Ltd. logo
RedHill Biopharma Ltd. RDHL
$ 6.4 0.0%
mail-toReport an Error

Annual report 2023
added 11-09-2024

report update icon

RedHill Biopharma Ltd. Financial Ratios 2011-2024 | RDHL

Annual Financial Ratios RedHill Biopharma Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 - - -12.3 -4.1 -42.6 -33.1 -19.9 -42.2 -52.0 -12.1 -7.4 -5.6 -

P/S

 - - 14.0 4.8 286.5 153.5 226.5 12278.8 365685.3 18.5 6560.2 3615.9 -

EPS

 - - -0.2 0.2 -0.1 -0.2 -0.3 -0.2 -0.2 - - - -

EV (Enterprise Value)

 15.4 M 187 M 1.34 B 447 M 1.79 B 1.27 B 903 M 1.2 B 1.08 B 134 M 81.1 M 58.9 M 1.4 M

EBITDA per Share

 - - -0.17 -1.66 -0.15 -0.17 -0.29 -0.237 -0.198 -1.23 -1.72 -1.71 -

EV/EBITDA

 -11.5 -6.1 -38.2 -50.3 -22.4 -38.9 -49.7 -11.7 -6.2 -4.6 -

PEG

 - -0.07 -0.02 2.24 1.47 1.42 2.1 -0.62 -0.41 -0.49 -0.15 -

P/B

 - - 135.3 22.4 30.0 25.1 20.1 19.8 18.3 5.2 6.6 3.0 -

P/CF

 - - -18.5 -6.4 -44.2 -37.2 -20.3 -43.7 -56.4 -9.8 -9.1 -8.4 -

ROE %

 - - - -549.43 -70.50 -75.84 -101.06 -46.84 -35.10 -42.83 -89.12 -54.30 -

ROA %

 - - -53.95 -42.26 -57.09 -62.20 -79.42 -39.58 -31.56 -37.12 -74.11 -51.38 -

ROCE %

 - - - -459.35 -68.05 -75.59 -114.19 -44.36 -35.88 -39.24 -90.33 -47.53 -

Current Ratio

 1.1 0.8 1.1 1.1 5.3 5.6 4.7 12.7 11.0 15.1 5.2 17.2 -

DSO

 - - - - - - - 357.8 - 55.4 12987.9 1916.2 -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - - - - - - 22.9 - - -

Operating Cycle

 - - - - - - - - - 55.4 - - -

Cash Conversion Cycle

 - - - - - - - - - 32.4 - - -

All numbers in USD currency

Quarterly Financial Ratios RedHill Biopharma Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 - - - - - - 0.06 - - - 0.04 - - - 0.04 - - - 0.05 - - - 0.06 - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

 - - - - - - -0.05 - - - -0.03 - - - -0.04 - - - -0.04 - - - -0.08 - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

 - - -98.44 -196.89 -196.89 -98.44 -144.84 -92.79 -92.79 -46.40 -80.59 -68.38 -68.38 -34.19 -77.11 -85.83 -85.83 -42.92 -65.50 -45.17 -45.17 -22.59 -22.59 - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

 - - -14.30 -28.60 -28.60 -14.30 -23.94 -19.29 -19.29 -9.65 -31.60 -43.90 -43.90 -21.95 -51.33 -58.75 -58.75 -29.38 -29.38 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROCE %

 - - -19.99 -39.98 -39.98 -19.99 -29.57 -19.16 -19.16 -9.58 -44.31 -69.47 -69.47 -34.73 -71.63 -73.78 -73.78 -36.89 -64.63 -55.48 -55.48 -27.74 -27.74 - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

 - - - - 1.1 - 1.2 - 1.1 - 1.3 - 5.3 - 2.8 - 5.6 - 3.2 - 4.7 - - - 6.5 - - - - - - - - - - - - - - - - - - - - - - -

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency